Stifel Financial’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Stifel Financial’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9,828	Closed	-$431K	–	3433
2021 Q4	$431K	Sell	9,828 -1,234	-11%	-$58.4K	﹤0.01%	2676
2021 Q3	$561K	Sell	11,062 -2,621	-19%	-$137K	﹤0.01%	2514
2021 Q2	$712K	Buy	13,683 +1,067	+8%	+$50.1K	﹤0.01%	2357
2021 Q1	$577K	Sell	12,616 -24,618	-66%	-$1.2M	﹤0.01%	2389
2020 Q4	$1.71M	Sell	37,234 -906	-2%	-$39.1K	﹤0.01%	1491
2020 Q3	$1.49M	Buy	38,140 +10,875	+40%	+$418K	﹤0.01%	1383
2020 Q2	$1.03M	Buy	+27,265	New	+$920K	﹤0.01%	1534

Other funds holding IDNA

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Stifel Financial's IDNA Position: Q1 2022 in Review

Stifel Financial sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2022, closing a stake of 9,828 shares — an estimated $431K sold.

Stifel Financial first reported a position in IDNA in Q2 2020 and held it in 7 quarters. The position peaked at $1.71M in Q4 2020. 86 funds tracked by Wall St. Rank hold IDNA as of Q1 2022.

Stifel Financial reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2022 after selling out during the quarter.
Stifel Financial sold 9,828 iShares Genomics Immunology and Healthcare ETF shares in Q1 2022, an estimated $431K.
Stifel Financial first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2020 and held it in 7 quarters.
Stifel Financial's iShares Genomics Immunology and Healthcare ETF position peaked at $1.71M in Q4 2020.
86 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2022.

Based on Stifel Financial's 13F filing for Q1 2022, filed 13 May 2022.